Current HIV/AIDS Reports

, Volume 9, Issue 2, pp 148–159

Therapeutic Options for Low Bone Mineral Density in HIV-Infected Subjects

Antiretroviral Therapies (A Pozniak, Section Editor)

DOI: 10.1007/s11904-012-0117-9

Cite this article as:
Cotter, A.G. & Mallon, P.W.G. Curr HIV/AIDS Rep (2012) 9: 148. doi:10.1007/s11904-012-0117-9


With the advent of effective antiretroviral therapy (ART), the recognition and management of long-term complications of HIV infection and ART are increasingly important for HIV physicians. Low bone mineral density (BMD) is more common in those with HIV infection and this review will outline therapeutic options for the management of low bone mineral density relevant to HIV-infected populations.


ManagementHIV infectionBone mineral densityOsteoporosisAntiretroviral therapies

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.HIV Molecular Research GroupUniversity College DublinDublin 7Ireland
  2. 2.Department of Infectious DiseasesMater Misericordiae University HospitalDublin 7Ireland